Distinguishing Recurrent Primary Brain Tumor from Radiation Injury: A Preliminary Study Using a Susceptibility-Weighted MR Imaging-Guided Apparent Diffusion Coefficient Analysis Strategy

被引:41
作者
Al Sayyari, A. [1 ]
Buckley, R. [4 ]
McHenery, C. [4 ]
Pannek, K. [1 ]
Coulthard, A. [4 ]
Rose, S. [1 ,2 ,3 ]
机构
[1] Univ Queensland, Ctr Magnet Resonance, Brisbane, Qld 4029, Australia
[2] Univ Queensland, Clin Res Ctr, Brisbane, Qld 4029, Australia
[3] Univ Queensland, Ctr Med Diagnost Technol Queensland, Brisbane, Qld 4029, Australia
[4] Royal Brisbane & Womens Hosp, Dept Med Imaging, Brisbane, Qld, Australia
关键词
HIGH-RESOLUTION; CONTRAST; GLIOMAS; DIFFERENTIATION;
D O I
10.3174/ajnr.A2011
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
BACKGROUND AND PURPOSE: The accurate delineation of tumor recurrence presents a significant problem in neuro-oncology. Our aim was to improve the identification of brain tumor recurrence from chemoradiation injury by using CE-SWI, a technique that provides improved visualization of the heterogeneous patterns of brain tumor pathology, to guide the analysis of ADC measures within the peritumoral territory. MATERIALS AND METHODS: Seventeen patients who were being treated for high-grade glial neoplasms took part in the study. All patients presented with new enhancing lesions on follow-up CE-T1. Recurrence or chemoradiation injury was confirmed from either histologic analysis or extensive clinical follow-up. Regions of enhancement on registered CE-SWI and CE-T1 images were extracted in a semiautomated fashion and transferred to coregistered ADC maps. Significant differences in ADC measures defined within the enhancement volumes on serial MR images were analyzed by using a nonparametric Kolmogorov-Smirnov approach and correlated with clinical follow-up diagnoses. RESULTS: Analysis of the serial data revealed that patients with a diagnosis of tumor recurrence had significantly reduced ADC measures within the enhancement volume delineated on CE-SWI. In contrast, patients with SD had significantly elevated ADC within the CE-SWI enhancement volume. CONCLUSIONS: The findings of an increase in enhancement volume delineated on serial CE-SWI maps, along with a concomitant reduction in ADC within this volume for patients with recurrent tumor, provide support for such an approach to be used to assist in follow-up patient management strategies.
引用
收藏
页码:1049 / 1054
页数:6
相关论文
共 18 条
[1]  
Asao C, 2005, AM J NEURORADIOL, V26, P1455
[2]   Clinical features, mechanisms, and management of pseudoprogression in malignant gliomas [J].
Brandsma, Dieto ;
Stalpers, Lukas ;
Taal, Walter ;
Sminia, Peter ;
van den Bent, Martinj .
LANCET ONCOLOGY, 2008, 9 (05) :453-461
[3]   Lymphomas and high-grade astrocytomas: Comparison of water diffusibility and histologic characteristics [J].
Guo, AC ;
Cummings, TJ ;
Dash, RC ;
Provenzale, JM .
RADIOLOGY, 2002, 224 (01) :177-183
[4]   Relationships between choline magnetic resonance spectroscopy, apparent diffusion coefficient and quantitative histopathology in human glioma [J].
Gupta, RK ;
Cloughesy, TF ;
Sinha, U ;
Garakian, J ;
Lazareff, J ;
Rubino, G ;
Rubino, L ;
Becker, DP ;
Vinters, HV ;
Alger, JR .
JOURNAL OF NEURO-ONCOLOGY, 2000, 50 (03) :215-226
[5]  
Hein PA, 2004, AM J NEURORADIOL, V25, P201
[6]   A global optimisation method for robust affine registration of brain images [J].
Jenkinson, M ;
Smith, S .
MEDICAL IMAGE ANALYSIS, 2001, 5 (02) :143-156
[7]   Added Value and Diagnostic Performance of Intratumoral Susceptibility Signals in the Differential Diagnosis of Solitary Enhancing Brain Lesions: Preliminary Study [J].
Kim, H. S. ;
Jahng, G. -H. ;
Ryu, C. W. ;
Kim, S. Y. .
AMERICAN JOURNAL OF NEURORADIOLOGY, 2009, 30 (08) :1574-1579
[8]  
Kono K, 2001, AM J NEURORADIOL, V22, P1081
[9]   Susceptibility-Weighted Imaging: Technical Aspects and Clinical Applications, Part 2 [J].
Mittal, S. ;
Wu, Z. ;
Neelavalli, J. ;
Haacke, E. M. .
AMERICAN JOURNAL OF NEURORADIOLOGY, 2009, 30 (02) :232-252
[10]   High-field, high-resolution, susceptibility-weighted magnetic resonance imaging: improved image quality by addition of contrast agent and higher field strength in patients with brain tumors [J].
Pinker, K. ;
Noebauer-Huhmann, I. M. ;
Stavrou, I. ;
Hoeftberger, R. ;
Szomolanyi, P. ;
Weber, M. ;
Stadlbauer, A. ;
Grabner, G. ;
Knosp, E. ;
Trattnig, S. .
NEURORADIOLOGY, 2008, 50 (01) :9-16